Bioton S.A.
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes m… Read more
Bioton S.A. - Asset Resilience Ratio
Bioton S.A. (BIO) has an Asset Resilience Ratio of 0.01% as of December 2017. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2005–2019)
This chart shows how Bioton S.A.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Bioton S.A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | zł0.00 | 0% |
| Short-term Investments | zł163.00K | 0.01% |
| Total Liquid Assets | zł163.00K | 0.01% |
Asset Resilience Insights
- Limited Liquidity: Bioton S.A. maintains only 0.01% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Bioton S.A. Industry Peers by Asset Resilience Ratio
Compare Bioton S.A.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for Bioton S.A. (2005–2019)
The table below shows the annual Asset Resilience Ratio data for Bioton S.A..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2019-12-31 | 0.20% | zł1.72 Million | zł881.42 Million | -2.28pp |
| 2016-12-31 | 2.47% | zł32.02 Million | zł1.30 Billion | +1.92pp |
| 2015-12-31 | 0.56% | zł6.95 Million | zł1.25 Billion | +0.53pp |
| 2013-12-31 | 0.03% | zł491.00K | zł1.89 Billion | -0.71pp |
| 2011-12-31 | 0.73% | zł14.83 Million | zł2.02 Billion | -0.87pp |
| 2010-12-31 | 1.61% | zł25.42 Million | zł1.58 Billion | +0.72pp |
| 2009-12-31 | 0.89% | zł14.32 Million | zł1.60 Billion | -1.35pp |
| 2008-12-31 | 2.24% | zł46.35 Million | zł2.06 Billion | +0.87pp |
| 2007-12-31 | 1.37% | zł21.23 Million | zł1.55 Billion | -5.08pp |
| 2006-12-31 | 6.46% | zł64.01 Million | zł991.63 Million | +6.00pp |
| 2005-12-31 | 0.46% | zł1.65 Million | zł358.12 Million | -- |